[1] |
宋高峰,张成珍,姬祥利. 丁螺环酮治疗精神分裂症阴性症状的效果及对认知功能的影响[J]. 中国医药导报,2022,19(16):161-164.
|
[2] |
DUNLEAVY C, ELSWORTHY R J, UPTHEGROVE R, et al. Inflammation in first-episode psychosis:the contribution of inflammatory biomarkers to the emergence of negative symptoms,a systematic review and meta-analysis[J]. Acta Psychiatr Scand, 2022, 146(1):6-20. DOI: 10.1111/acps.13416.
|
[3] |
JANNATI A, OBERMAN L M, ROTENBERG A, et al. Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation[J]. Neuropsychopharmacology, 2023, 48(1):191-208. DOI: 10.1038/s41386-022-01453-8.
|
[4] |
LEFAUCHEUR J P, ALEMAN A, BAEKEN C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation(rTMS):an update(2014-2018)[J]. Clin Neurophysiol, 2020, 131(2):474-528. DOI: 10.1016/j.clinph.2019.11.002.
|
[5] |
SCIORTINO D, PIGONI A, DELVECCHIO G, et al. Role of rTMS in the treatment of cognitive impairments in bipolar disorder and schizophrenia:a review of Randomized Controlled Trials[J]. J Affect Disord, 2021, 280(Pt A):148-155. DOI: 10.1016/j.jad.2020.11.001.
|
[6] |
JEMNA N, ZDRENGHEA A C, FRUNZA G, et al. Theta-burst stimulation as a therapeutic tool in neurological pathology:a systematic review[J]. Neurol Sci, 2024, 45(3):911-940. DOI: 10.1007/s10072-023-07144-6.
|
[7] |
|
[8] |
HUA J P Y, ABRAM S V, FORD J M. Cerebellar stimulation in schizophrenia:a systematic review of the evidence and an overview of the methods[J]. Front Psychiatry, 2022, 13:1069488. DOI: 10.3389/fpsyt.2022.1069488.
|
[9] |
BASAVARAJU R, ITHAL D, THANKI M V, et al. Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms:a randomized controlled trial[J]. Schizophr Res, 2021, 238:108-120. DOI: 10.1016/j.schres.2021.10.005.
|
[10] |
|
[11] |
|
[12] |
LIM K, PEH O H, YANG Z X, et al. Large-scale evaluation of the Positive and Negative Syndrome Scale(PANSS)symptom architecture in schizophrenia[J]. Asian J Psychiatr, 2021, 62:102732. DOI: 10.1016/j.ajp.2021.102732.
|
[13] |
GALDERISI S, MUCCI A, DOLLFUS S, et al. EPA guidance on assessment of negative symptoms in schizophrenia[J]. Eur Psychiatry, 2021, 64(1):e23. DOI: 10.1192/j.eurpsy.2021.11.
|
[14] |
LYSTAD J U, FALKUM E, MOHN C, et al. The MATRICS Consensus Cognitive Battery(MCCB):performance and functional correlates[J]. Psychiatry Res, 2014, 220(3):1094-1101. DOI: 10.1016/j.psychres.2014.08.060.
|
[15] |
FADEN J, CITROME L. Schizophrenia:one name,many different manifestations[J]. Med Clin North Am, 2023, 107(1):61-72. DOI: 10.1016/j.mcna.2022.05.005.
|
[16] |
MEESTERS P D. New horizons in schizophrenia in older people[J]. Age Ageing, 2023, 52(9):afad161. DOI: 10.1093/ageing/afad161.
|
[17] |
FAN F M, HUANG J C, TAN S P, et al. Association of cortical thickness and cognition with schizophrenia treatment resistance[J]. Psychiatry Clin Neurosci, 2023, 77(1):12-19. DOI: 10.1111/pcn.13486.
|
[18] |
LEE H H, TREVIZOL A P, MULSANT B H, et al. Retreatment with theta burst stimulation(TBS)for late life depression(LLD):a retrospective chart review[J]. J Psychiatr Res, 2023, 164:454-457. DOI: 10.1016/j.jpsychires.2023.06.040.
|
[19] |
TSENG P T, ZENG B S, HUNG C M, et al. Assessment of noninvasive brain stimulation interventions for negative symptoms of schizophrenia:a systematic review and network meta-analysis[J]. JAMA Psychiatry, 2022, 79(8):770-779. DOI: 10.1001/jamapsychiatry.2022.1513.
|
[20] |
ROSSON S, FILIPPIS R D, CROATTO G, et al. Brain stimulation and other biological non-pharmacological interventions in mental disorders:an umbrella review[J]. Neurosci Biobehav Rev, 2022, 139:104743. DOI: 10.1016/j.neubiorev.2022.104743.
|
[21] |
|
[22] |
GARG S, SINHA V K, TIKKA S K, et al. The efficacy of cerebellar vermal deep high frequency(theta range)repetitive transcranial magnetic stimulation(rTMS)in schizophrenia:a randomized rater blind-sham controlled study[J]. Psychiatry Res, 2016, 243:413-420. DOI: 10.1016/j.psychres.2016.07.023.
|
[23] |
TIKKA S K, GODI S M, SIDDIQUI M A, et al. Evidence from Indian studies on safety and efficacy of therapeutic transcranial magnetic stimulation across neuropsychiatric disorders- a systematic review and meta-analysis[J]. Indian J Psychiatry, 2023, 65(1):18-35. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_572_22.
|
[24] |
JIN Y, TONG J, HUANG Y, et al. Effectiveness of accelerated intermittent theta burst stimulation for social cognition and negative symptoms among individuals with schizophrenia:a randomized controlled trial[J]. Psychiatry Res, 2023, 320:115033. DOI: 10.1016/j.psychres.2022.115033.
|
[25] |
ZHANG J J, YANG Y Y, AL-AHMADY Z S, et al. Maternal exposure to PM2.5 induces cognitive impairment in offspring via cerebellar neuroinflammation and oxidative stress[J]. Ecotoxicol Environ Saf, 2023, 249:114425. DOI: 10.1016/j.ecoenv.2022.114425.
|
[26] |
CHENG X L, XIE Y, WANG A Z, et al. Correlation between elevated serum interleukin-1β,interleukin-16 levels and psychiatric symptoms in patients with schizophrenia at different stages[J]. BMC Psychiatry, 2023, 23(1):396. DOI: 10.1186/s12888-023-04896-5.
|
[27] |
VALIULIENE G, VALIULIS V, DAPSYS K, et al. Brain stimulation effects on serum BDNF,VEGF,and TNFα in treatment-resistant psychiatric disorders[J]. Eur J Neurosci, 2021, 53(11):3791-3802. DOI: 10.1111/ejn.15232.
|
[28] |
MONEM R G, OKUSAGA O O. Repetitive transcranial magnetic stimulation:a potential treatment for obesity in patients with schizophrenia[J]. Behav Sci, 2021, 11(6):86. DOI: 10.3390/bs11060086.
|
[29] |
|
[30] |
POORGANJI M, GOEKE K, ZOMORRODI R, et al. The use of theta burst stimulation in patients with schizophrenia - a systematic review[J]. Schizophr Res, 2023, 261:245-255. DOI: 10.1016/j.schres.2023.10.005.
|